SYSBIOTECH

SYSBIOTECH

Graz, Austria· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.3M

Overview

Founded in 2010 and based in Graz, Austria, SYSBIOTECH operates as a specialized equipment and solutions provider for the biotech industry, particularly in synthetic biology and biologics manufacturing. The company's core business is designing and supplying customizable fermentation and downstream processing systems, from benchtop to industrial scale. It has demonstrated relevance in critical areas, such as supplying equipment for COVID-19 vaccine manufacturing, and actively participates in major industry events like ACHEMA. SYSBIOTECH appears to be a private, revenue-generating company serving research institutes and production facilities.

Synthetic BiologyBiologics

Technology Platform

Integrated bioprocessing equipment platform for fermentation, separation, filtration, and lyophilization across lab, pilot, and industrial scales.

Funding History

2
Total raised:$3.3M
Grant$800K
Seed$2.5M

Opportunities

Growth is driven by the expanding global biologics and synthetic biology markets, which require specialized fermentation and downstream processing equipment.
The trend towards decentralized manufacturing and pandemic preparedness creates demand for flexible, scalable solutions that SYSBIOTECH provides.

Risk Factors

The company faces intense competition from large global bioprocess equipment suppliers and may have cyclical, project-dependent revenue.
It must continuously innovate to keep pace with industry shifts towards single-use systems and digitalization.

Competitive Landscape

SYSBIOTECH competes in the fragmented bioprocess equipment market against major multinational corporations (e.g., Sartorius, Thermo Fisher) and other specialized European engineering firms. Its differentiation likely lies in customization, integrated solutions, and focus on the pilot-scale bridge between R&D and production.